CIK 0001376339 · Large accelerated filer
MIMEDX GROUP, INC.
Sign in to watch- Ticker
- MDXG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 262792552
- Phone
- (770) 651-9100
- Business address
- 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
- Former names
- Alynx, Co.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-10 | Phelan William Lawrence Chief Accounting Officer | Sale | −1,595 | $5.93 | $9K | 184,219 |
| 2023-05-10 | Carlson Peter M Chief Financial Officer | Sale | −5,976 | $5.93 | $35K | 656,435 |
| 2023-05-04 | Stein Robert Benjamin President, Regenerative Med. | Sale | −51,756 | $5.34 | $276K | 337,644 |
| 2023-05-02 | Phelan William Lawrence Chief Accounting Officer | Sale | −5,200 | $3.80 | $20K | 185,814 |
| 2023-04-25 | Hulse William Frank IV General Counsel and CAO | Sale | −5,988 | $3.74 | $22K | 462,434 |
| 2023-04-25 | Phelan William Lawrence Chief Accounting Officer | Sale | −1,628 | $3.74 | $6K | 191,014 |
| 2023-04-25 | Stein Robert Benjamin President, Regenerative Med. | Sale | −5,987 | $3.74 | $22K | 389,400 |
| 2023-04-25 | Carlson Peter M Chief Financial Officer | Sale | −6,094 | $3.74 | $23K | 662,411 |
| 2023-04-11 | Hulse William Frank IV General Counsel and CAO | Sale | −5,995 | $3.31 | $20K | 468,422 |
| 2023-04-11 | Phelan William Lawrence Chief Accounting Officer | Sale | −1,632 | $3.31 | $5K | 192,642 |
| 2023-04-11 | Stein Robert Benjamin President, Regenerative Med. | Sale | −5,996 | $3.31 | $20K | 395,387 |
| 2023-04-11 | Carlson Peter M Chief Financial Officer | Sale | −6,100 | $3.31 | $20K | 668,505 |
| 2023-03-13 | Hulse William Frank IV General Counsel and CAO | Grant or award | +136,364 | $4.62 | $630K | 474,417 |
| 2023-03-13 | Carlson Peter M Chief Financial Officer | Grant or award | +140,455 | $4.62 | $649K | 674,605 |
| 2023-03-13 | Stein Robert Benjamin President, Regenerative Med. | Grant or award | +135,065 | $4.62 | $624K | 401,383 |
| 2023-03-13 | Phelan William Lawrence Chief Accounting Officer | Grant or award | +53,030 | $4.62 | $245K | 194,274 |
| 2023-03-07 | Hulse William Frank IV General Counsel and CAO | Sale | −11,308 | $4.24 | $48K | 338,053 |
| 2023-03-07 | Carlson Peter M Chief Financial Officer | Sale | −12,056 | $4.24 | $51K | 534,150 |
| 2023-03-07 | Stein Robert Benjamin President, Regenerative Med. | Sale | −12,355 | $4.24 | $52K | 266,318 |
| 2023-03-07 | Phelan William Lawrence Chief Accounting Officer | Sale | −3,396 | $4.24 | $14K | 141,244 |
Page 6 of 7 · 126 trades